Identification of Burkholderia spp. in the clinical microbiology laboratory: Comparison of conventional and molecular methods

Journal of Clinical Microbiology

Volumn 37, Issue 7, 1999, Pages 2158-2164

  Van Pelt, Cindy ^a   Verduin, Cees M ^a   Goessens, Wil H F ^a   Vos, Margreet C ^a   Tümmler, Burkhard ^b   Segonds, Christine ^d   Reubsaet, Frans ^c   Verbrugh, Henri ^a   Van Belkum, Alex ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c Zentrum Biochem Zentrum K   (Germany)

^d CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BURKHOLDERIA; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DEVICE; DIAGNOSTIC TEST; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RALSTONIA; SPUTUM ANALYSIS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0033026743     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.7.2158-2164.1999     Document Type: Article

References (39)

1. Barker, P. M., R. E. Wood, and P. H. Gilligan. 1997. Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration. Pediatr. Pulmonol. 23:123-125.
2. Bauernfeind, A., I. Schneider, R. Jungwirth, and C. Roller. 1998. Discrimination of Burkholderia species detectable in cystic fibrosis patients by PCR. J. Clin. Microbiol. 36:2748-2751.
3. Baxter, I. A., P. A. Lambert, and I. N. Simpson. 1997. Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli. J. Antimicrob. Chemother. 39:169-175.
4. Bevinino, A., S. Tabacchioni, L. Chiarini, M. V. Carusi, M. del Gallo, and P. Visca. 1994. Phenotypic comparison between rhizosphere and clinical isolates of Burkholderia cepacia. Microbiology 140:1069-1077.
5. Boom, R., C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. M. E. Wertheimvan Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
6. Burdge, D. R., M. A. Noble, M. E. Campbell, V. L. Krell, and D. P. Speert. 1995. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin. Infect. Dis. 20:445-448.
7. Di Cello, F., A. Bevivino, L. Chiarini, R. Fani, D. Paffetti, S. Tabacchioni, and C. Dalmastri. 1997. Biodiversity of a Burkholderia cepacia population isolated from the maize rhizosphere at different plant growth stages. Appl. Environ. Microbiol. 63:4485-4493.
8. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
9. 2-fixing isolates from rice in Vietnam. Int. J. Syst. Bacteriol. 45:274-289.
10. Govan, J. R. W., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
11. Govan, J. R. W., J. E. Hughes, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
12. Govan, J. R. W., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
13. Graves, M., T. Robin, A. M. Chipman, J. Wong, S. Khashe, and J. M. Janda. 1997. Four additional cases of Burkholderia gladioli infection with microbiological correlates and review. Clin. Infect. Dis. 25:838-842.
14. Hales, B. A., J. A. W. Morgan, C. A. Hart, and C. Winstanley. 1998. Variation in flagellin genes and proteins of Burkholderia cepacia. J. Bacteriol. 180: 1110-1118.
15. Henry, D. A., M. E. Campbell, J. J. LiPuma, and D. P. Speert. 1997. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J. Clin. Microbiol. 35:614-619.
16. Henry, D. A. Personal communication.
17. Hoare, S., and A. J. Cant. 1996. Chronic granulomatous disease presenting as severe sepsis due to Burkholderia gladioli. Clin. Infect. Dis. 23:411.
18. Holmes, A., J. Govan, and R. Goldstein. 1998. Agriculture use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg. Infect. Dis. 4:221-227.
19. Kanji, S. S., V. Tapson, R. D. Davis, J. Madden, and I. Browning. 1997. Infections in patients with cystic fibrosis following lung transplantation. Chest 112:924-930.
20. Khan, S. U., S. M. Gordon, P. C. Stillwell, T. J. Kirby, and A. C. Arroliga. 1996. Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation. Pediatr. Infect. Dis. J. 15:637-639.
21. Kiska, D. L., A. Kerr, M. C. Jones, J. A. Carracciolo, B. Eskridge, M. Jordan, S. Miller, D. Hughes, N. King, and P. H. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:886-891.
22. Landa A. S., F. M. Sipkema, J. Weijma, A. A. Beenackers, J. Dolfing, and D. B. Janssen. 1994. Cometabolic degradation of trichloroethylene by Pseudomonas cepacia G4 in a chemostat with toluene as the primary substrate. Appl. Environ. Microbiol. 60:3368-3374.
23. LiPuma, J. J. 1998. Burkholderia cepacia: management issues and new insights. Clin. Chest Med. 19:473-486.
24. Mahenthiralingam, E., D. A. Simpson, and D. P. Speert. 1997. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J. Clin. Microbiol. 35:808-816.
25. Mahenthiralingam, E., M. E. Campbell, D. A. Henry, and D. P. Speert. 1996. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J. Clin. Microbiol. 34:2914-2920.
26. O'Callaghan, E. M., M. S. Tanner, and G. J. Boulnois. 1994. Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia. J. Clin. Pathol. 47:222-226.
27. Pitt, T. L., and J. R. W. Govan. 1993. Pseudomonas cepacia and cystic fibrosis. PHLS Microbiol. Dig. 10:69-72.
28. Ross, J., S. M. Holland, V. J. Gill, E. S. DeCarlo, and J. I. Gallin. 1995. Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases. Clin. Infect. Dis. 21: 1291-1293.
29. Segonds, C., T. Heulin, N. Marty, and G. Chabanon. 1999 Differentiation of Burkholderia species by PCR-restriction fragment analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J. Clin. Microbiol. 37:2201-2208.
30. Shin, J. H., S. H. Kim, M. G. Shin, S. P. Suh, D. W. Ryang, and M. H. Jeong. 1997. Bacteremia due to Burkholderia gladioli: case report. Clin. Infect. Dis. 25:1264-1265.
31. Smith, D. L., L. B. Gumery, E. G. Smith, D. E. Stableforth, M. E. Kaufmann, and T. L. Pitt. 1993. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J. Clin. Microbiol. 31:3017-3022.
32. Sun, L., R. Jiang, S. Steinbach, A. Holmes, C. Campanelli, J. Forstner, U. Sajjan, Y. Tan, M. Riley, and R. Goldstein. 1995. The emergence of a highly transmissible lineage of abl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat. Med. 1:661-665.
33. Tabacchioni, S., P. Visca, L. Chiarini, A. Bevinino, C. di Serio, S. Fancelli, and R. Fani. 1995. Molecular characterisation of rhizosphere and clinical isolates of Burkholderia cepacia. Res. Microbiol. 144:531-542.
34. Tablan, O. C., L. A. Carson, L. B. Cusick, L. A. Bland, W. J. Martone, and W. R. Jarvis. 1987. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J. Clin. Microbiol, 25:485-487.
35. Tyler, S. D., C. A. Strathdee, K. R. Rozee, and W. M. Johnson. 1995. Primers designed to differentiate pathogenic pseudomonads on the basis of the sequencing of genes coding for 16S-23S rRNA internal transcribed spacers. Clin. Diagn. Lab. Immunol. 4:448-453.
36. Vandamme, P., G. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauers, M. Gillis, K. Kersters, and J. R. V. Govan. 1997. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int. J. Syst. Bacteriol. 47:1188-1200.
37. Weisburg, W. G., S. M. Barns, D. A. Pelletier, and D. J. Lane. 1991. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173:697-703.
38. Welch, D. F., M. J. Muszynski, C. H. Pai, M. J. Marcon, M. M. Hribar, P. H. Gilligan, J. M. Matsen, P. A. Ahlin, B. C. Hilman, and S. A. Chartrand. 1987. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J. Clin. Microbiol. 25:1730-1734.
39. Yabuuchi, E., Y. Kosako, I. Yano, H. Hotta, and Y. Nishiuchi. 1995. Transfer of two Burkholderia and an Alcaligenes species to Ralstonia gen. nov.: proposal of Ralstonia pickettii (Ralston, Palleromi and Doudoroff 1973) comb. nov., Ralstonia solanacearum (Smith 1896) comb. nov. and Ralstonia eutropha (Davis 1969) comb. nov. Microbiol. Immunol. 39:897-904.